Warner-lambert Company

Prosidion Limited

Geoffrey Martyn Williams

Martin James Procter

Matthew Colin Thor Fyfe

Karen Lesley Schofield

Vilasben Kanji Shah

Daniel Y Du

David James Witter

Arlindo Lucas Castelhano

Kosuke Yasuda

Chrystelle Marie Rasamison

Lisa Sarah Gardner

Maseo Nawano

Lisa Sarah Bertram

Compounds of Formula (I): or pharmaceutically acceptable salts or N-oxides thereof, are useful in the prophylactic and therapeutic treatment of hyperglycemia and diabetes.

Tri(cyclo) substituted amide glucokinase activator compounds

The present invention is directed to a new class of 6-benzyl urea/thiourea-quinolin-2-one derivatives and 2-oxo-6-benzylurea/thiourea-chromene derivatives. These compound are androgen antagonists and are useful in the treatment of alopecia, acne and other conditions associated with inappropriate activation of the androgen receptor.

Benzyl urea and thiourea derivatives

The present invention is directed to a new class of 6-benzylsulfonamido-quinoline/chromene derivatives, to their use as androgen antagonists, and to formulations containing these androgen antagonists.

Benzyl sulfonamide derivatives

The invention is directed to a new class of quinolin-zene and z-exc chromen compounds that have been derivatized at the 6-position with a urea or this urea moet, and to then use as androgen antagonists.

Urea and thiourea derivatives

The present invention is directed to a new class of 6-sulfonamido-quinolin-2-one and 6-sulfonamido-2-oxo-chromene derivatives to their use as androgen antagonists, and to relieve conditions associated with inappropriate activation of the androgen receptor.

Androgen receptor antagonists

The present invention is directed to a new class of 6-sulfonamide quinoline and chromene derivative and to their use as androgen antagonists.

Growing community of inventors

Oxford, United Kingdom

Geoffrey Martyn Williams